文献速递血液净化与透析慢性肾脏病

高敏对比传统心肌肌钙蛋白T在2型糖尿病维持性血液透析患者中的预后价值

Prognostic Value of High-Sensitivity Versus Conventional Cardiac Troponin T Assays Among Patients With Type 2 Diabetes Mellitus Undergoing Maintenance Hemodialysis.
PubMed 文献 · Am J Kidney Dis · 2018-01-06

本研究基于4D随机对照试验的队列分析,纳入1255例2型糖尿病维持性血液透析患者,中位随访4年。在1034例同时具有高敏和传统肌钙蛋白T检测值的患者中,505例死亡、377例发生心血管事件。两种检测方法测得的肌钙蛋白T均与死亡和心血管事件相关;高敏法可测出传统法判为正常的低浓度肌钙蛋白T,且这些低浓度仍与死亡相关。

要点

  • 高敏肌钙蛋白T检测可识别传统法判为正常但预后不良的透析患者。
  • 肌钙蛋白T浓度与2型糖尿病透析患者的长期死亡和心血管事件相关。
  • 高敏法测得的极低浓度肌钙蛋白T仍具有预后价值。

核心结论

  • 在2型糖尿病维持性血液透析患者中,心肌肌钙蛋白T与长期死亡率和心血管结局相关。
  • 高敏法可测出传统法无法精确测量的低浓度肌钙蛋白T,且这些浓度与不良预后相关。

研究设计与样本

  • 基于随机对照试验的队列分析,数据来自德国糖尿病与透析研究(4D)。
  • 纳入1255例终末期肾病合并2型糖尿病维持性血液透析患者,中位随访4年。
  • 在1034例两种检测方法均有有效测量的亚组中进行分析。

主要发现

  • 在1034例参与者中,505例死亡,377例发生心血管事件。
  • 高敏肌钙蛋白T和传统肌钙蛋白T浓度在调整心血管危险因素和透析相关变量后均与死亡和心血管事件相关。
  • 455例(44%)高敏肌钙蛋白T浓度极低(<50ng/L)的患者会被传统法归类为正常,而高敏肌钙蛋白T浓度仍与死亡相关。

临床怎么用

  • 对2型糖尿病维持性血液透析患者,可考虑使用高敏肌钙蛋白T检测进行风险分层。
  • 传统法判为正常的低浓度肌钙蛋白T患者仍可能存在不良预后风险。

局限性

  • 研究仅纳入2型糖尿病患者,可能限制普适性。
  • 研究结果尚未经过外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mortality is high among patients undergoing hemodialysis for whom cardiac troponin concentration is a strong predictor of outcome. Modern troponin assays allow measurement of very low concentrations. STUDY DESIGN: Using data from a randomized controlled trial, a cohort analysis to evaluate the prognostic value of very low cardiac troponin T (TnT) concentrations. SETTING & PARTICIPANTS: 1,255 patients with end-stage renal disease and type 2 diabetes mellitus undergoing maintenance hemodialysis from the German Diabetes and Dialysis Study (4D) who had a median follow-up of 4 years. INDEX TEST, REFERENCE TEST, AND OUTCOME: Cardiac TnT was measured using a high-sensitivity assay (hs-TnT) and a conventional assay (conventional TnT) in a subpopulation (n=1,034) with valid measurements for both assays. Outcome measures were all-cause mortality and a composite cardiovascular end point including cardiac death, myocardial infarction, or stroke. RESULTS: Among the 1,034 study participants, 505 died and 377 had a cardiovascular event. Both hs-TnT and conventional TnT concentrations were associated with mortality and cardiovascular events in models adjusted for cardiovascular risk factors and dialysis-associated variables. 455 (44%) patients with very low TnT concentrations (hs-TNT < 50ng/L) would have been classified as normal by the conventional TnT assay. Among these patients, hs-TnT concentrations were also associated with mortality. LIMITATIONS: The study of patients with type 2 diabetes may limit generalizability. These findings have not been externally validated. CONCLUSIONS: In patients with type 2 diabetes mellitus receiving hemodialysis, cardiac TnT is associated with long-term mortality and cardiovascular outcomes. Concentrations of TnT not measurable with acceptable precision using a conventional TnT assay were associated with a poor prognosis when measured using a high-sensitivity assay.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Keller T, Wanner C, Krane V, et al. Prognostic Value of High-Sensitivity Versus Conventional Cardiac Troponin T Assays Among Patients With Type 2 Diabetes Mellitus Undergoing Maintenance Hemodialysis. Am J Kidney Dis. 2018. PMID: 29310884. doi:10.1053/j.ajkd.2017.10.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。